Identity
Carnosine (INCI: Carnosine) is a dipeptide — two amino acids, β-alanine and L-histidine, joined as β-alanyl-L-histidine. It occurs naturally in muscle tissue and is studied widely as an antioxidant, metal chelator, and anti-glycation agent. In skincare it is used as a supporting antioxidant, usually under the "anti-ageing" and "anti-glycation" banners.
Two separations keep it honest. It is not N-acetyl carnosine (a related molecule marketed for eye drops) and not anserine (a methylated relative) — different substances that should not be treated as the same ingredient. And crucially, its impressive biology is mostly established by a route that isn't a serum.
Mechanism (as proposed)
Carnosine's antioxidant and anti-glycation activity — interfering with the reactions that cross-link proteins into advanced glycation end-products (AGEs) — is real and well documented in vitro and in oral / systemic studies. That is the source of the "anti-glycation, anti-AGE, cellular anti-ageing" marketing.
The gap is delivery. Almost none of that evidence is for a topical carnosine on intact skin, and the leap from "chelates metals and blocks glycation in a test tube or when eaten" to "reverses glycation in your dermis from a serum" is not supported. What a cosmetic can honestly offer is a modest supporting antioxidant role for the appearance of skin — graded C on thin, largely mechanistic evidence — while the anti-glycation and anti-AGE claims sit at D for topical use. Judge it as a supporting antioxidant peptide, and keep the anti-AGE story with the oral and laboratory literature where it actually lives.